JAYDESS système intra-utérin SIU 13.5mg

7680626880014 CH-62688 G02BA03 09.02.2.

Active substances:

JAYDESS système intra-utérin SIU 13.5mg
JAYDESS système intra-utérin SIU 13.5mg
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6268801
CPT
-
Packaging group
1
Unit
Stück
Composition
levonorgestrelum 13.5 mg, cum liberatione max. 14 µg/24 h, poly(dimethylsiloxani) elastomerum, silica colloidalis anhydrica, polyethylenum, barii sulfas, argentum, E 172 (nigrum), pro praeparatione.

Articles (1)

Jaydess 10 mcg/24 Stunden, Intrauterines Wirkstofffreisetzungssystem
Intrauterines Wirkstofffreisetzungssystem
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/02/2022
Patient information leaflet
Français
18/02/2022
Patient information leaflet
Italien
18/02/2022
Professional SmPC
Allemand
18/02/2022
Professional SmPC
Français
18/02/2022
Professional SmPC
Italien
18/02/2022

Detailed composition

Substance Quantity Type Category
levonorgestrelum
13.5 MG Substance Wirkstoff (Principe actif)
poly(dimethylsiloxani) elastomerum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
polyethylenum
- Substance HNIDK
barii sulfas
- Substance HNIDK
argentum
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
62688
Drug name
Jaydess, Intrauterines Wirkstofffreisetzungssystem
Galenic form
IUWFS
ATC Code
G02BA03
Authorization status
Z
Dispensation category
B
First authorization
29/10/2013
Authorization expiration date
31/12/9999
IT number
09.02.2.
Domain
Human medicine
Field of application
Kontrazeption

Packaging details

Description (FR)
JAYDESS système intra-utérin SIU 13.5mg
Description (DE)
JAYDESS Intrauterinsystem IUS 13.5 mg
Market launch
29/10/2013
Narcotic (BTM)
No
Buy us a coffee Explore the data